149 related articles for article (PubMed ID: 11391761)
1. Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
Svetel M; Sternić N; Pejović S; Kostić VS
Mov Disord; 2001 May; 16(3):568-9. PubMed ID: 11391761
[TBL] [Abstract][Full Text] [Related]
2. [Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson's disease].
Farallo M; Amoruso C; Frattini C; Ardissino G; Nebbia G
Pediatr Med Chir; 2012; 34(5):234-6. PubMed ID: 23342748
[TBL] [Abstract][Full Text] [Related]
3. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
4. Wilson's disease.
Walshe JM
Lancet; 2007 Mar; 369(9565):902. PubMed ID: 17368141
[No Abstract] [Full Text] [Related]
5. Neurologic deterioration in a child with Wilson's disease on penicillamine therapy.
Paul AC; Varkki S; Yohannan NB; Eapen CE; Chandy G; Raghupathy P
Indian J Gastroenterol; 2003; 22(3):104-5. PubMed ID: 12839386
[TBL] [Abstract][Full Text] [Related]
6. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
[No Abstract] [Full Text] [Related]
7. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
8. Patient with late-onset Wilson's disease: deterioration with penicillamine.
Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
[No Abstract] [Full Text] [Related]
9. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
10. Potential hepatotoxicity of penicillamine treatment in three patients with Wilson's disease.
Deutscher J; Kiess W; Scheerschmidt G; Willgerodt H
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):628. PubMed ID: 10554138
[No Abstract] [Full Text] [Related]
11. Penicillamine should not be used as initial therapy in Wilson's disease.
Brewer GJ
Mov Disord; 1999 Jul; 14(4):551-4. PubMed ID: 10435490
[No Abstract] [Full Text] [Related]
12. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
Kobayashi S; Kodama H; Inuzuka R; Mori Y; Yanagawa Y
Pediatr Int; 2005 Oct; 47(5):589-91. PubMed ID: 16190972
[No Abstract] [Full Text] [Related]
14. Elastosis perforans serpiginosa in a patient with Wilson's disease.
Thwaites PA; Khan SA; Asadi K; Angus PW
Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):144. PubMed ID: 28403984
[No Abstract] [Full Text] [Related]
15. Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
Ibáñez-Samaniego L; Ochoa-Palominos A; Catalina-Rodríguez MV; Salcedo-Plaza M; Clemente-Ricote G
Rev Esp Enferm Dig; 2015 Mar; 107(3):190-1. PubMed ID: 25733050
[No Abstract] [Full Text] [Related]
16. Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.
Chen Y; Qiu Y; Chen M; Jiang Y; Qiu X; Gao L
Australas J Dermatol; 2023 Feb; 64(1):126-130. PubMed ID: 36565232
[TBL] [Abstract][Full Text] [Related]
17. Penicillamine: the treatment of first choice for patients with Wilson's disease.
Walshe JM
Mov Disord; 1999 Jul; 14(4):545-50. PubMed ID: 10435489
[No Abstract] [Full Text] [Related]
18. Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease.
Hill VA; Seymour CA; Mortimer PS
Br J Dermatol; 2000 Mar; 142(3):560-1. PubMed ID: 10777259
[No Abstract] [Full Text] [Related]
19. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
